Navigation Links
Bone Drugs May Also Battle Breast Cancer, Researchers Say
Date:12/7/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Dec. 7 (HealthDay News) -- A drug developed to treat osteoporosis appears to boost survival in women with certain types of breast cancer, according to two new studies.

These preliminary findings regarding the bone-building drug zoledronic acid potentially give scores of women more options to battle their tumors. The studies are slated for presentation at the San Antonio Breast Cancer Symposium this week.

The first looked at premenopausal women with estrogen receptor-positive breast cancer receiving either the bone drug plus hormone therapy or a placebo plus hormone therapy for three years.

Earlier data from this study were encouraging, and this update -- 84 months after the trial's start -- provides further evidence of improved disease-free survival and recurrence rates among women receiving zoledronic acid. The drug is known by the brand names Reclast and Zometa.

The new research shows that women receiving zoledronic acid had a 28 percent reduced risk for recurrence and a 36 percent reduced risk for dying.

Women over the age of 40 received the most benefit, the researchers said.

"In general, the overall survival is excellent, which demonstrates that treating these patients without adjuvant chemotherapy is a very good approach," said study author Dr. Michael Gnant, a professor of surgery at the Medical University of Vienna, Austria. He said the study received academic and not pharmaceutical funding.

Many women were still seeing the benefit four and five years after their treatment stopped. "This means we've changed something in the beginning in terms of the disease," Gnant said.

Cancer patients often take bone-building drugs, commonly referred to as bisphosphonates, to prevent fractures related to spread of the cancer to the bone. But zoledronic acid is not an approved treatment for breast cancer in many countries, including the Uni
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. The private sale of drugs in public hospitals
2. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
3. Adapting to clogged airways makes common pathogen resist powerful drugs
4. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
5. Drugs That Shift Cells Energy Find New Purpose
6. FDA Tightens Controls on Anemia Drugs
7. FDA Issues Warning on Key Asthma Drugs
8. Two Tulsa Pharmacies Penalized for Missing Prescription Drugs
9. Tests to Measure Safety of Anti-Clotting Drugs of Limited Value
10. Notch-blocking drugs kill brain cancer stem cells, yet multiple therapies may be needed
11. Scans Might Monitor Success of Alzheimers Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bone Drugs May Also Battle Breast Cancer, Researchers Say  
(Date:8/28/2014)... 2014 UWDress.com, an internationally famous designer ... unveiled its fashionable assortment of fall bridesmaid dresses ... and old customers, the company is now providing big ... company’s discounted fall bridesmaid outfits are offered in many ... collection are priced less than $190. UWDress.com’s kind officials ...
(Date:8/28/2014)... these particular arguments against the policy, put forward by ... the first country in the world to introduce standardised ... Ireland, and the UK are currently considering similar legislation. ... policy would deter people from buying their tobacco from ... of cheap products sourced from Asia, and increase the ...
(Date:8/28/2014)... Recently, iFitDress.com, the distinguished wedding dress manufacturer and retailer, ... dresses . Included in the new range are hundreds ... are provided at deeply discounted prices, from 22 to ... and reliable delivery service. All clients from around the ... time. As is commonly noted, international customers have different ...
(Date:8/28/2014)... of women who are given information about the chance ... not fully understand the risks involved, according to research ... , today (Friday). , In a survey of around ... London (UCL) found that 64 per cent felt they ... chance that screening will pick up cancers that would ...
(Date:8/28/2014)... 2014 Blood's Thicker Than Water is based ... family ties in the heart of the city. Raymond E. ... story about how disrespect caused two families to collide with ... , The Yayo Boyz and the M.O.B. Boyz clash in ... local onlookers in a silent terror. "Guerrilla," AKA "Real," runs ...
Breaking Medicine News(10 mins):Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2Health News:Plain cigarette packs don't hurt small retailers or boost trade in illicit tobacco 2Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2
... (June 24, 2010) The nerve cell-damaging plaque that ... builds up in the retinas of the eyes ... prospect that noninvasive optical imaging of the eyes could ... disease, according to new research. Scientists discovered characteristic ...
... of large sessile colorectal polyps is increasingly used as ... its technical difficulty, the high risk of complications such ... malignancy. This research, lead by Dr. Sohn DK ... demonstrated the safety of endoscopic piecemeal resection (EPMR) for ...
... may increase the risk of severe asthma attacks among people ... Harvard Medical School, Harvard Pilgrim Health Care Institute and Brigham ... on the American Thoracic Society,s journal Web site ahead of ... and Critical Care Medicine . "We found that the ...
... School of Medicine has received a $5.3 million grant from ... four-year clinical trial to show the effects of weight loss ... co-existing medical conditions in overweight breast cancer survivors. ,This ... study that will examine the effect of weight loss on ...
... coping with stress succumb easily to substance use cravings, ... to behavioral researchers. "Cravings are a strong predictor of ... development, Penn State. "The goal of this study is ... person on a within-day basis. Because recovery must be ...
... A pair of University of California San Diego researchers ... and disorders, and Yang Xu, an immunologist have ... from the California Institute for Regenerative Medicine (CIRM). ... Immunology awards totaling $25 million that were approved at ...
Cached Medicine News:Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 2Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 3Health News:Moldy homes a serious risk for severe asthma attacks in some 2Health News:UC San Diego researcher awarded $5.3 million for breast cancer survivorship study 2Health News:Ignoring stress leads recovering addicts to more cravings 2Health News:UCSD researchers receive $2.5 million in new stem cell grants 2
(Date:8/28/2014)... -- Pharmatech initiated enrollment for its AccessPPM program ... for matching cancer patients to cancer clinical trials. ... cancers, disease staging, and genetic mutations - which ... the first place. The challenge that the industry ... well known to the patient or even their ...
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin Pharmaceutical ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today updates the timeline ... Facility (QLF). The Company is ... dataset for China Food & Drug Administration,s (CFDA) ...
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... May 30, 2012   AssureRx Health, Inc. ... Series C financing. The personalized medicine company, which ... right drug for individual neuropsychiatric patients, will use ... two flagship pharmacogenomic products, GeneSightRx® Psychotropic and GeneSightRx® ...
... 2012 The use of an armband-based body monitoring ... approaches to weight loss examined by researchers in an ... of Sports Medicine,s 59th Annual Meeting and 3rd ... in San Francisco. The study, "An Economic Analysis of ...
Cached Medicine Technology:AssureRx Health Raises $12.5 Million Series C Financing 2AssureRx Health Raises $12.5 Million Series C Financing 3AssureRx Health Raises $12.5 Million Series C Financing 4Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 2Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 3
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
... Control is designed to ... significant range of those ... during fertility or pregnancy ... hCG-Beta Subunit levels allow ...
... provides the clinical laboratory with the ... for monitoring immunoassay and therapeutic drug ... separate controls. Made from human serum ... suitable for most methods and is ...
Lyphochek Immunology Plus Control is an assayed control for monitoring chemistry procedures that test for autoimmune, anemic, malignant, hepatic and nephrotic-disease states. Available in two levels....
Medicine Products: